![News](https://firebrickpharmabucket.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2021/11/23084701/hero-banner.jpg)
News
Peter Molloy on the Nasodine SARS-CoV-2 data and the Firebrick vision
10 Feb 2022
“Our goal is to create a successful Australian pharmaceutical business that is globally-facing…and I hope that in the next five years we will see Nasodine sold in most countries around the world.”